Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Spice up your spuds: study tests glucose monitors on potato meals

NCT ID NCT07254624

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a continuous glucose monitor can accurately measure blood sugar changes after eating a starchy vegetable (potato) with or without herbs and spices. Ten healthy adults without diabetes will wear a glucose monitor for at least 10 days and eat test meals. The goal is to better understand how different food combinations affect glucose response.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 10 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Nov 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * body mass index (BMI): 20-35 * no dietary restriction or food allergies to study items * weight stable * access to a smart phone * willingness to wear a continuous glucose monitor for the duration of the study (at minimum 10 days) Exclusion Criteria: * pregnancy or anticipating pregnancy or lactation * food allergy to study items * diagnosed diabetes (type 1 or 2) or taking diabetes medications * history of bariatric surgery * consumed \>1 serving of potatoes daily before enrollment * 5% weight loss or gain within the past 6 months * medical conditions or medication that would prevent the ability to comply with the treatment assignment and/or affect blood glucose or energy balance * condition which would prevent the ability to wear a continuous glucose monitor on the upper arm for the study duration

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Post-prandial glucose response are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Alabama at Birmingham

    Birmingham, Alabama, 35294, United States